Biomarker Correlates of Clinical Outcomes from a Global phase 1b Study of JNJ-90014496, CD20/CD19 Bi-Specific Chimeric Antigen Receptor (CAR) T-cell Therapy for Patients with Large B-cell Lymphoma (LBCL)Mahipal Suraneni, Vicki Plaks, Luke Mountjoy et al.|Transplantation and Cellular Therapy|2026Cited by 0